Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
The United Nations launched the Decade of Restoration Program to focus on protecting and rebuilding ecosystems around the globe.
RFD-TV’s Tammi Arender and the Tennessee Beef Council make an easy, nutritious beef recipe to add to your summer cookbook.
Groups around the country are experimenting with methods of resurrecting a once abundant and beloved tree that was virtually wiped out by disease in the 20th century.
